Active Surveillance for Screen-detected Low- and Intermediate-risk Prostate Cancer: Extended Follow-up up to 25 Years in the GÖTEBORG-1 Trial

Journal:
European Urology
Published:
DOI:
10.1016/j.eururo.2025.06.012
Affiliations:
3
Authors:
4
Go to article
Institutions Authors Share
Sahlgrenska Academy, GU, Sweden
2.500000
 0.63
Sahlgrenska University Hospital (SU), GU, Sweden
1.000000
 0.25
Skaraborg Hospital Skövde, Sweden
0.500000
 0.13
Interested in Oncology and Carcinogenesis?